OncoSec Medical Incorporated (ONCSQ)

OncoSec Medical Cash Flow Statement

Financials in millions USD. Fiscal year is August - July.

Year Ending	TTM	Jul 31, 2022	Jul 31, 2021	Jul 31, 2020	Jul 31, 2019	Jul 31, 2018
Net Income	-29.39	-34.18	-45.17	-42.25	-30.28	-39.14
Depreciation & Amortization	0.94	1.07	1.08	0.99	0.24	0.33
Share-Based Compensation	1.28	1.65	5.14	3.52	3.5	0
Other Operating Activities	2.17	-0.67	-2.84	4.6	-2.47	15.58
Operating Cash Flow	-24.99	-32.14	-41.79	-33.15	-29	-23.22
Capital Expenditures	-0.02	-0.24	-0.8	0	-0.01	-0.07
Acquisitions	0	0	0	0	0	0
Change in Investments	-	-	-	-	-23.21	-27.72
Other Investing Activities	-	-	-	-	46.43	4.5
Investing Cash Flow	-0.01	-0.24	-0.8	0	23.2	-23.29
Dividends Paid	0	0	0	0	-0	0
Common Stock Issued	2.84	0.2	62.84	30	27.9	32.28
Share Repurchases	0	0	0	-0.18	-0	0
Other Financing Activities	0.7	-1.37	5.37	-1.78	-0.7	6.6
Financing Cash Flow	3.54	-1.16	68.21	28.4	27.2	38.88
Net Cash Flow	-21.55	-33.65	25.6	-4.79	21.34	-7.64
Free Cash Flow	-25.01	-32.38	-42.59	-33.15	-29.01	-23.29
Free Cash Flow Per Share	-9.67	-18.13	-28.48	-44.10	-90.50	-127.69

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.